Business News | Concept Medical Group Company and Envision Scientific Pvt Ltd Win “Best Exporter 2021-22” Award from SurSEZ under Ministry of Trade and Industry

Surat (Gujarat) [India]May 7 (ANI/PNN): Surat-based Envision Scientific Private Limited (ESPL), a Concept Medical Group company, has been awarded the “Best Exporter of the Year-2021-22” award for being the top exporter in the Medical Device Industry by Surat Special Economic Zone (SurSEZ) under special initiatives of MCI (Ministry of Commerce and Industry) on Thursday, May 5, 2022.

The Best Exporter of the Year 2021-22 was presented to Bhavdeep Doshi, Director of the company at the awards ceremony held under the chairmanship of SurSEZ Development Commissioner, Virendra Singh (ITS), and Asst. CGST Commissioner and Specified Customs Officer, SEZ, SACHIN, Ashok Singh (IRS).

Read also | Inter Milan keep Serie A hopes alive with victory over Empoli.

SurSEZ has become the 2nd contributor to exports from SEZs in India. SurSEZ’s exports increased significantly by 20% to reach Rs 22,035 crore in 2021-2022 from Rs 17,845 crore in the previous year.

“SurSEZ is the second largest contributor to India’s overall exports. India’s overall exports grew from $292 billion in 20-21 to $420 billion in 21-22, an increase of 44% and the highest on record to date. We would like to thank contributors like Envision Scientific Pvt Ltd and Concept Medical Group for making this possible at SurSEZ,” said Virendra Singh, Development Commissioner, SurSEZ at the ceremony.

Read also | Canara Bank Recruitment 2022: Apply for Assistant Manager, Deputy Manager and other positions at canmoney.in; Check the details here.

ESPL, incorporated in 2008, is the sole manufacturing entity for all the innovative products of the Concept Medical group. The group of companies is a market leader in drug delivery technology in the medical device industry and holds more than 100 patents for its products, technology and combination devices. The company develops a variety of medical devices used for intervention in coronary artery disease (CAD) and peripheral arterial disease (PAD).

Concept Medical Group is among the 21 applicants approved by the central government under the Production Linked Incentive (PLI) for the successful commissioning of the project and additional sales of the Indian-made medical device.

Recently, the Union Minister for Chemicals and Fertilizers, Mansukh Mandaviya, said that the medical device sector in the country has huge potential for growth in domestic and global markets and companies should take a step significant step forward in strengthening the national supply chain by participating in the PLI scheme.

“It is a great joy for us to be awarded the Best Exporter 2021-22 award in the category of Medical Devices. The Government of India’s PLI program will go a long way in reducing the dependence on the import of raw materials and equipment. as we already possess proprietary technology to create world-class products by combining the Bare Metal Stent (BMS) project.Through this Green Field project, the PLI program will generate significant job opportunities by generating national added value (DVA) This will be a big plus for our many ongoing and planned clinical trials globally with the increased production of our SurSEZ unit We are sure to double the number of exports with more production and development. self-reliance under this project in the coming times, helping India to become the global market leader in Medical Devices and Pharmaceutical Industry with availability and pro abundant production, which is also the vision of our honorable PM Modi.” quoted, Dr. Manish Doshi (founder and managing director – Concept Medical group of companies).

According to Dr. Manish, in-house manufacturing of stents offers a good cost trade-off compared to the cost of imported stents which require a longer storage period and sometimes impose less flexibility in the product line.

Concept Medical is a maverick in the field of drug delivery technology and medical devices with its famous drug-eluting stents and drug-coated balloons, both highly acclaimed and recognized worldwide. The group company is the fastest growing company in its industry and is a trendsetter in the truest sense of the word. The company’s products have made a name for themselves in the international market for the treatment of coronary heart disease and peripheral arteries, thanks to its proprietary technology. ESPL’s (Concept Medical) SurSEZ unit is the largest drug-eluting stent and drug-coated balloon manufacturing unit in Asia; a tremendous achievement in itself.

This story is provided by PNN. ANI shall in no way be responsible for the content of this article. (ANI/PNN)

(This is an unedited and auto-generated story from syndicated newsfeed, LatestLY staff may not have edited or edited the body of the content)